TAK-137, an AMPA-R potentiator with little agonistic effect, has a wide therapeutic window.
Kunugi, A., Tanaka, M., Suzuki, A., Tajima, Y., Suzuki, N., Suzuki, M., Nakamura, S., Kuno, H., Yokota, A., Sogabe, S., Kosugi, Y., Awasaki, Y., Kaku, T., Kimura, H.(2019) Neuropsychopharmacology 44: 961-970
- PubMed: 30209408 
- DOI: 10.1038/s41386-018-0213-7
- Primary Citation of Related Structures:  
5ZG0, 5ZG1, 5ZG2, 5ZG3 - PubMed Abstract: 
Activation of α-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid receptor (AMPA-R) is a promising strategy to treat psychiatric and neurological diseases if issues of bell-shaped response and narrow safety margin against seizure can be overcome. Here, we show that structural interference at Ser743 in AMPA-R is a key to lower the agonistic effect of AMPA-R potentiators containing dihydropyridothiadiazine 2,2-dioxides skeleton ...